A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patients.

In order to assess the role of maintenance melphalan and prednisone (MP) in responding multiple myeloma patients, 185 eligible patients who responded to initial MP with stabilization for at least 4 months were randomized to either stop treatment and resume therapy at relapse or to continue MP until...

Descripción completa

Detalles Bibliográficos
Autores principales: Belch, A., Shelley, W., Bergsagel, D., Wilson, K., Klimo, P., White, D., Willan, A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1988
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246700/
https://www.ncbi.nlm.nih.gov/pubmed/3279997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246700/
https://www.ncbi.nlm.nih.gov/pubmed/3279997

Ejemplares similares